Back to top

Image: Bigstock

Is a Surprise Coming for Medpace (MEDP) This Earnings Season?

Read MoreHide Full Article

Investors are always looking for stocks that are poised to beat at earnings season and Medpace Holdings, Inc. (MEDP - Free Report) may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.

That is becauseMedpaceis seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat. After all, analysts raising estimates right before earnings — with the most up-to-date information possible — is a pretty good indicator of some favorable trends underneath the surface for MEDP in this report.

In fact, the Most Accurate Estimate for the current quarter is currently at 43 cents per share for MEDP, compared to a broader Zacks Consensus Estimate of 42 cents per share. This suggests that analysts have very recently bumped up their estimates for MEDP, giving the stock a Zacks Earnings ESP of +2.38% heading into earnings season.

Medpace Holdings, Inc. Price and EPS Surprise

Medpace Holdings, Inc. Price and EPS Surprise

Medpace Holdings, Inc. price-eps-surprise | Medpace Holdings, Inc. Quote

Why is this Important?

A positive reading for the Zacks Earnings ESP has proven to be very powerful in producing both positive surprises, and outperforming the market. Our recent 10-year backtest shows that stocks that have a positive Earnings ESP and a Zacks Rank #3 (Hold) or better show a positive surprise nearly 70% of the time, and have returned over 28% on average in annual returns (see more Top Earnings ESP stocks here).

Given that MEDP has a Zacks Rank #3 (Hold) and an ESP in positive territory, investors might want to consider this stock ahead of earnings. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Clearly, recent earnings estimate revisions suggest that good things are ahead for Medpace, and that a beat might be in the cards for the upcoming report.

Zacks’ Single Best Pick to Double

From thousands of stocks, 5 Zacks experts each picked their favorite to gain +100% or more in months to come. From those 5, Zacks Director of Research, Sheraz Mian hand-picks one to have the most explosive upside of all.

With users in 180 countries and soaring revenues, it’s set to thrive on remote working long after the pandemic ends. No wonder it recently offered a stunning $600 million stock buy-back plan.

The sky’s the limit for this emerging tech giant. And the earlier you get in, the greater your potential gain.

Click Here, See It Free >>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Medpace Holdings, Inc. (MEDP) - free report >>

Published in